For example, the loss of EHF has been found to promote epithelial-mesenchymal transition and cell migration in conditions such as prostate cancer (18, 19), lung cancer (20, 21), pancreatic cancer, and esophageal squamous cell carcinoma. The gene discussed is EHF; the disease is prostate cancer.